Lucid Diagnostics Inc. Q4 2025 Earnings Call Summary

1 hour ago 2

Moby Intelligence

Thu, March 26, 2026 astatine 12:13 PM CDT 3 min read

Achieved grounds Q4 trial measurement of 3,664, exceeding the people scope of 2,500 to 3,000, driven by improved income squad productivity and established marketplace presence.
Secured a U.S. Department of Veterans Affairs (VA) declaration nether the Federal Supply Schedule, validating the Medicare pricing of $938 and providing entree to 9 cardinal enrolled veterans.
Identified a 'de facto' sum pathway with UnitedHealthcare by leveraging endoscopy guidelines that database EsoGuard arsenic an due indicator for EGD procedures.
Transitioned the commercialized team's absorption from high-volume event-based investigating toward higher-value Medicare and VA objective populations to hole for imminent reimbursement shifts.
Released real-world information from 12,000 patients confirming a 95% method occurrence complaint and information profile, which absorption is utilizing to differentiate EsoGuard from 'antiquated' sponge-based competitors.
Attributed the hold successful the Medicare draught Local Coverage Determination (LCD) to administrative and logistical backlogs astatine MolDx alternatively than concerns implicit objective utility.

Anticipates the work of a draught Medicare LCD 'any time now,' which would trigger a 45-day remark play followed by a last argumentation and 12-month retroactive outgo eligibility.
Plans to denote the archetypal affirmative sum argumentation from a Laboratory Benefit Manager (LBM) wrong the adjacent mates of months, facilitating determination Blue Cross Blue Shield adoption.
Intends to support existent operating disbursal levels until Medicare sum is finalized, astatine which constituent the institution volition 'step connected the gas' regarding income unit expansion.
Developing blase cost-effectiveness modeling to supplement ongoing negotiations with commercialized payers who necessitate economical information beyond objective validity.
Prioritizing EHR integration with systems similar Epic to streamline doc ordering and effect delivery, viewed arsenic a captious request for objective scaling successful 2026.

Reported a currency equilibrium of $34.7 cardinal with a quarterly pain complaint of astir $11.1 million, including investments successful marketplace entree staffing.
Noted that 80% of billable amounts are presently not collected owed to the transitional signifier of reimbursement, requiring gross designation connected a currency ground for astir claims.
Highlighted a $7.7 cardinal non-cash disbursal complaint for the twelvemonth related to the mark-to-market valuation of convertible notes driven by a 33% summation successful banal price.
Confirmed that PAVmed remains the largest shareholder with an 18% stake, maintaining important power alongside absorption contempt losing implicit voting control.